Clinical Trials

Aduhelm: still controversial months after FDA’s “accelerated approval”

August 19, 2021 — 0 Comments

Clinical Trials, Research Strategy

Gene editing for amyloid (!?!?!?!?) Beyond aducanumab, but it’s not Alzheimer beta-amyloid

August 6, 2021 — 0 Comments

Cognitive studies

Cognition, Stardust & Photons: Fun With Mind-Body Dualism, “Cassiopeia’s Dust”

June 29, 2021 — 0 Comments

Clinical Trials

Aducanumab: FDA “accelerated approval” is conditional

June 7, 2021 — 0 Comments

Clinical Trials

Waiting: the FDA & aducanumab

June 4, 2021 — 0 Comments

Clinical Trials

Donanemab P2 “encouraging”: Really? It Misses Investigators’ Own Target; Cognitive Enhancers Up Next…

May 6, 2021 — 0 Comments

Clinical Trials, Research Strategy

Exercise & The Little Gray Cells in AD? Eye Opening Paper May Refute That…

April 6, 2021 — 0 Comments

Clinical Trials

“Alzheimer’s Germ Quest”: no $1M winner, but 8 candidate germs!? Other Alzheimer $MM Challenges…

March 1, 2021 — 1 Comment

Clinical Trials, Research Strategy

Off BACE: 70 Year Olds Bounce Back From BACE Drug Cognitive Decline?!

February 7, 2021 — 0 Comments

Funding, Research Administration, Research Strategy

Begley: AD Amyloid ‘cabal” thwarted progress toward a cure for decades

January 28, 2021 — 0 Comments